Improving the health of the tuberculosis drug pipeline
Talha Burki
Jan. 23, 2014, 1:41 p.m.
After 40 years of no new therapies, approval of bedaquiline and delamanid for the treatment of tuberculosis is a cause for optimism. But is that hope well founded?
